Low CCR3 Expression Is a Marker of Active Disease in Chronic Spontaneous Urticaria.
作者信息
Bellamy Crisjana, Chichester Kristin, Saini Sarbjit, Oliver Eric T
机构信息
Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
Clin Exp Allergy. 2024 Sep;54(9):703-705. doi: 10.1111/cea.14523. Epub 2024 Jun 17.
Abstract
摘要
相似文献
1
Low CCR3 Expression Is a Marker of Active Disease in Chronic Spontaneous Urticaria.
Clin Exp Allergy. 2024 Sep;54(9):703-705. doi: 10.1111/cea.14523. Epub 2024 Jun 17.
2
The Predictive Value of Serum Total IgE for Antihistamine Treatment Outcomes in Chinese Patients with Chronic Spontaneous Urticaria.
Acta Derm Venereol. 2025 Aug 3;105:adv43568. doi: 10.2340/actadv.v105.43568.
3
MRGPRX2 gain-of-function mutation drives enhanced mast cell reactivity in chronic spontaneous urticaria.
J Allergy Clin Immunol. 2025 Jul;156(1):159-170. doi: 10.1016/j.jaci.2025.03.007. Epub 2025 Mar 18.
4
Chronic inducible urticaria - having more than one is common and clinically relevant.
Front Immunol. 2025 Jun 30;16:1584771. doi: 10.3389/fimmu.2025.1584771. eCollection 2025.
5
Diagnostic Use of CCR3, CD63, CD203c and FcεRIα on Blood Leukocytes of Allergic Asthma and Combined Allergic Rhinitis and Asthma Syndrome.
J Cell Mol Med. 2025 Jun;29(12):e70594. doi: 10.1111/jcmm.70594.
6
Biomarkers of response to omalizumab in patients with chronic spontaneous urticaria.
Allergol Immunopathol (Madr). 2025 Jul 1;53(4):7-13. doi: 10.15586/aei.v53i4.1343. eCollection 2025.
7
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.
JAMA Dermatol. 2024 Sep 1;160(9):927-935. doi: 10.1001/jamadermatol.2024.2056.
8
Endotypes of chronic spontaneous urticaria and angioedema.
J Allergy Clin Immunol. 2025 Jul;156(1):17-23. doi: 10.1016/j.jaci.2025.04.004. Epub 2025 Apr 10.
9
Effect of combining histaglobulin with antihistamines in patients with chronic spontaneous urticaria in a tertiary care hospital setting- a randomized trial.
Arch Dermatol Res. 2025 Mar 1;317(1):516. doi: 10.1007/s00403-025-04045-w.
10
Omalizumab Treated Urticaria Patients Display T Cell and Thrombocyte-Associated Gene Regulation.
Immun Inflamm Dis. 2025 Feb;13(2):e70132. doi: 10.1002/iid3.70132.
本文引用的文献
1
Urticaria.
Nat Rev Dis Primers. 2022 Sep 15;8(1):61. doi: 10.1038/s41572-022-00389-z.
2
Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.
Int Arch Allergy Immunol. 2019;179(1):21-30. doi: 10.1159/000496162. Epub 2019 Mar 15.
3
Evaluation of CCR3 as a basophil activation marker.
Am J Clin Pathol. 2013 Sep;140(3):293-300. doi: 10.1309/AJCPLSN0RQKHJX1A.
4
Serum eotaxin levels in patients with chronic spontaneous urticaria.
Eur Ann Allergy Clin Immunol. 2012 Oct;44(5):188-92.
5
CCR3: a key to mast cell phenotypic and functional diversity?
Am J Respir Cell Mol Biol. 2003 Apr;28(4):405-9. doi: 10.1165/rcmb.F265.
6
Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers.
J Immunol. 2002 Sep 1;169(5):2712-8. doi: 10.4049/jimmunol.169.5.2712.
7
Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists.
Am J Respir Crit Care Med. 2002 Jun 15;165(12):1602-9. doi: 10.1164/rccm.200111-059OC.
8
Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils.
J Biol Chem. 2002 Jul 19;277(29):26012-20. doi: 10.1074/jbc.M201803200. Epub 2002 Apr 29.
9
IL-3 induces down-regulation of CCR3 protein and mRNA in human eosinophils.
J Immunol. 2001 Sep 15;167(6):3443-53. doi: 10.4049/jimmunol.167.6.3443.
Zotero 插件